Bio-Techne (TECH) reported fiscal fourth-quarter net sales of $321.2 million, up 1% from the prior year, with organic revenue up 3%. GAAP diluted EPS was $0.35, compared with a loss of $0.11 per share a year earlier.
For fiscal 2026, net sales were $1.2 billion, flat with the prior year. The company said it is no longer holding investor conference calls for quarterly results following its announced agreement to be acquired by Merck KGaA, Darmstadt, Germany.
- Fourth-quarter net earnings were $54.6 million, compared with a net loss of $17.7 million a year earlier.
- GAAP operating income was $74.3 million, compared with an operating loss of $23.9 million in the prior-year quarter.
- Full-year GAAP EPS was $1.16 per diluted share, compared with $0.46 in fiscal 2025.
- Bio-Techne agreed to be acquired for $73 per share in cash in a transaction with an enterprise value of about $11.3 billion.
- Protein Sciences fourth-quarter net sales were $231.2 million, while Diagnostics and Spatial Biology net sales were $90.1 million.
$TECH Insider Trading Activity
$TECH insiders have traded $TECH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TECH stock by insiders over the last 6 months:
- AMY E. HERR sold 1,976 shares for an estimated $116,791
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$TECH Hedge Fund Activity
We have seen 233 institutional investors add shares of $TECH stock to their portfolio, and 357 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 6,884,967 shares (+678.3%) to their portfolio in Q1 2026, for an estimated $359,808,375
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 2,394,205 shares (-99.8%) from their portfolio in Q2 2026, for an estimated $169,150,583
- DURABLE CAPITAL PARTNERS LP added 2,367,126 shares (+113.3%) to their portfolio in Q1 2026, for an estimated $123,706,004
- SELECT EQUITY GROUP, L.P. removed 2,127,315 shares (-75.0%) from their portfolio in Q1 2026, for an estimated $111,173,481
- RUANE, CUNNIFF & GOLDFARB L.P. added 1,926,066 shares (+131.4%) to their portfolio in Q1 2026, for an estimated $100,656,209
- BLACKROCK, INC. added 1,761,303 shares (+14.4%) to their portfolio in Q2 2026, for an estimated $124,436,056
- AMUNDI added 1,754,926 shares (+2426.8%) to their portfolio in Q2 2026, for an estimated $123,985,521
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$TECH Congressional Stock Trading
Members of Congress have traded $TECH stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $TECH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 04/08, 03/26, 02/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
